Monoclonal Antibody Therapy Plus Sargramostin in Treating Patients With Advanced Neuroblastoma

NCT00002560 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Neuroblastoma

Interventions

BIOLOGICAL: monoclonal antibody 3F8
BIOLOGICAL: sargramostim

Sponsor

Memorial Sloan Kettering Cancer Center